Torrent Pharmaceuticals Acquires Stake in J.B. Chemicals
Filing Summary
Torrent Pharmaceuticals Ltd has completed the acquisition of 7,44,81,519 equity shares of J.B. Chemicals & Pharmaceuticals Limited, representing 46.39% of its equity share capital. This transaction was finalized on January 21, 2026, following a share purchase agreement with Tau Investment Holdings Pte. Ltd. The company now holds a total of 7,44,82,836 shares, including those acquired through an open offer, and is classified as a promoter of J.B. Chemicals. This acquisition aligns with Torrent Pharmaceuticals’ strategic objectives.
Torrent Pharmaceuticals Ltd has announced the completion of its acquisition of 7,44,81,519 equity shares of J.B. Chemicals & Pharmaceuticals Limited on January 21, 2026. This acquisition represents 46.39% of the equity share capital of J.B. Chemicals on a fully diluted basis.
The shares were acquired from Tau Investment Holdings Pte. Ltd. under a share purchase agreement dated June 29, 2025, with an addendum on July 3, 2025. Following this transaction, Torrent Pharmaceuticals has been classified as a promoter of J.B. Chemicals.
In addition to the shares acquired from Tau Investment Holdings, Torrent Pharmaceuticals also acquired 1,317 equity shares of J.B. Chemicals through an open offer. This brings the total holding to 7,44,82,836 shares, maintaining the 46.39% stake in the company.
Torrent Pharmaceuticals is a leading pharmaceutical company focused on the development, manufacturing, and marketing of a wide range of branded and generic formulations. The company is committed to expanding its market presence and enhancing its product portfolio through strategic acquisitions and partnerships.